Responses
Poster Group 3A – Wednesday, September 28, 2005
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY
Compose a Response to This Article
Other responses
No responses have been published for this article.